| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |